Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Eupraxia Pharmaceuticals (EPRX) Debt Ratio (2022 - 2024)

Updated

Eupraxia Pharmaceuticals' Debt Ratio was -0.01 in Q4 2024, compared with 0.52 a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Debt Ratio (2022 - 2024) Analysis & Trends

From Q4 2022 onward, Eupraxia Pharmaceuticals has reported Debt Ratio for 5 quarters.

  • In earlier years, Debt Ratio was 0.52 in FY2023 and 0.01 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Eupraxia Pharmaceuticals 304.87 Mn -174.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -0.01
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.52
Dec 31, 2022 0.01
API Access

Eupraxia Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=EPRX&period=max&api_key=YOUR_API_KEY